Annual ROE
-207.47%
-123.96%-148.44%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual return on equity is -207.47%, with the most recent change of -123.96% (-148.44%) on December 31, 2023.
- During the last 3 years, XLO annual ROE has fallen by -273.77% (-412.93%).
- XLO annual ROE is now -412.93% below its all-time high of 66.30%, reached on December 31, 2020.
Performance
XLO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-214.74%
-38.23%-21.66%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly return on equity is -214.74%, with the most recent change of -38.23% (-21.66%) on September 30, 2024.
- Over the past year, XLO quarterly ROE has dropped by -88.19% (-69.69%).
- XLO quarterly ROE is now -168.31% below its all-time high of 314.37%, reached on December 31, 2021.
Performance
XLO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XLO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -148.4% | -69.7% |
| 3 y3 years | -412.9% | -69.7% |
| 5 y5 years | - | -69.7% |
XLO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -407.5% | at low | -168.3% | +37.4% |
| 5 y | 5-year | -412.9% | at low | -168.3% | +37.4% |
| alltime | all time | -412.9% | at low | -168.3% | +37.4% |
Xilio Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -214.74%(+21.7%) |
| Jun 2024 | - | -176.51%(+13.5%) |
| Mar 2024 | - | -155.56%(+22.9%) |
| Dec 2023 | -207.47%(+148.4%) | -126.55%(+20.9%) |
| Sep 2023 | - | -104.69%(+19.3%) |
| Jun 2023 | - | -87.74%(+13.0%) |
| Mar 2023 | - | -77.68%(+19.4%) |
| Dec 2022 | -83.51% | -65.07%(+18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -54.95%(-39.7%) |
| Jun 2022 | - | -91.19%(-73.4%) |
| Mar 2022 | - | -343.28%(-209.2%) |
| Dec 2021 | -40.88%(-161.7%) | 314.37%(+364.9%) |
| Sep 2021 | - | 67.62%(-8.3%) |
| Jun 2021 | - | 73.74%(+17.5%) |
| Mar 2021 | - | 62.74%(+46.8%) |
| Dec 2020 | 66.30%(+13.1%) | 42.73% |
| Dec 2019 | 58.64% | - |
FAQ
- What is Xilio Therapeutics annual return on equity?
- What is the all time high annual ROE for Xilio Therapeutics?
- What is Xilio Therapeutics annual ROE year-on-year change?
- What is Xilio Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly ROE year-on-year change?
What is Xilio Therapeutics annual return on equity?
The current annual ROE of XLO is -207.47%
What is the all time high annual ROE for Xilio Therapeutics?
Xilio Therapeutics all-time high annual return on equity is 66.30%
What is Xilio Therapeutics annual ROE year-on-year change?
Over the past year, XLO annual return on equity has changed by -123.96% (-148.44%)
What is Xilio Therapeutics quarterly return on equity?
The current quarterly ROE of XLO is -214.74%
What is the all time high quarterly ROE for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly return on equity is 314.37%
What is Xilio Therapeutics quarterly ROE year-on-year change?
Over the past year, XLO quarterly return on equity has changed by -88.19% (-69.69%)